Manual batch review creates dangerous latency between result availability and clinician awareness. A rising troponin or a new mass on a CT scan requires immediate action, but when buried in a daily report queue, it can be overlooked for hours. This operational bottleneck directly impacts patient safety and outcomes, while also exposing health systems to legal and reputational risk from delayed diagnosis. The business case is clear: reduce time-to-intervention to improve quality metrics and avoid costly adverse events.




